Evidence map›Paper›PMID 39598513›Full record

ArticlePharmaceutics2024

Design of Experiments to Tailor the Potential of BSA-Coated Peptide Nanocomplexes for Temozolomide/p53 Gene Co-Delivery.

Inês Afonso, Ana R Neves, Dalinda Eusébio, Tânia Albuquerque, Eric Vivès, Prisca Boisguérin, Adriana O Santos, Ângela Sousa, Diana Costa

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Inês AfonsoCICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6200-506 Covilhã, Portugal.
Ana R NevesCICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6200-506 Covilhã, Portugal.
Dalinda EusébioCICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6200-506 Covilhã, Portugal.ORCID 0000-0003-3292-2184
Tânia AlbuquerqueCICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6200-506 Covilhã, Portugal.
Eric VivèsPhyMedExp, Université de Montpellier, INSERM, CNRS, 34295 Montpellier, France.ORCID 0000-0001-5391-9641
Prisca BoisguérinPhyMedExp, Université de Montpellier, INSERM, CNRS, 34295 Montpellier, France.ORCID 0000-0002-6955-1340
Adriana O SantosCICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6200-506 Covilhã, Portugal.ORCID 0000-0002-1224-9191
Ângela SousaCICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6200-506 Covilhã, Portugal.ORCID 0000-0001-9155-7581
Diana CostaCICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6200-506 Covilhã, Portugal.ORCID 0000-0002-5049-4518

Funding

Fundação para a Ciência e Tecnologia CICS-UBI projects UIDB/00709/2020 and UIDP/00709/2020; CICS-UBI base grant with DOI 10.54499/UIDB/00709/2020 (https://doi.org/10.54499/UIDB/00709/2020) and the CICS-UBI programmatic grant with DOI 10.54499 /UIDP/00709/2020 (https://doi.org/10.54499/UIDP/0
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BSA-coated nanoparticlescombined therapydesign of experimentsglioblastoma therapyWRAP-peptides

Identifiers

PMID39598513
PMCPMC11597296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.